THIOSALICYLIC ACID

Details

Stereochemistry	ACHIRAL
Molecular Formula	C7H6O2S
Molecular Weight	154.186
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC(=O)C1=C(S)C=CC=C1

InChI

InChIKey=NBOMNTLFRHMDEZ-UHFFFAOYSA-N

InChI=1S/C7H6O2S/c8-7(9)5-3-1-2-4-6(5)10/h1-4,10H,(H,8,9)

HIDE SMILES / InChI

Molecular Formula	C7H6O2S
Molecular Weight	154.186
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: ISBN: 978-0-7637-6547-7, 'Nurse's Drug 2009' (2009), p. 949, Retrieved from https://books.google.com/books?id=pobp8JRNW1MC&pg | https://www.ncbi.nlm.nih.gov/pubmed/13563950

Thiosalicylic acid is an analgesic and anti-inflammatory agent. It is used (in form of sodium salt) to relieve symptoms of acute gout, painful musculoskeletal conditions, osteoarthritis and rheumatic fever. The drug exerts its action by inhibiting prostaglandin synthesis. Thiosalicylic acid usage is associated with the risk of contact dermatitis.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
prostaglandin biosynthetic process 23 Target ID: GO:0001516 Sources: ISBN: 978-0-7637-6547-7, 'Nurse's Drug 2009' (2009), p. 949, Retrieved from https://books.google.com/books?id=pobp8JRNW1MC&pg	Inhibitor 8297

Conditions

Condition	Modality	Highest Phase	Product
Acute gout 3 Sources: (2009) 'Nurse's Drug 2009', p. 949, retrieved from: https://books.google.com/books?id=pobp8JRNW1MC&pg	Palliative	Not Provided 504	REXOLATE Approved Use To relieve symptoms of acute gout, to relieve pain from musculoskeletal conditions, to relieve symptoms of osteoarthritis, to treat rheumatic fever.
Musculoskeletal conditions 6 Sources: (2009) 'Nurse's Drug 2009', p. 949, retrieved from: https://books.google.com/books?id=pobp8JRNW1MC&pg	Palliative	Not Provided 504	REXOLATE Approved Use To relieve symptoms of acute gout, to relieve pain from musculoskeletal conditions, to relieve symptoms of osteoarthritis, to treat rheumatic fever.
Osteoarthritis 157 Sources: (2009) 'Nurse's Drug 2009', p. 949, retrieved from: https://books.google.com/books?id=pobp8JRNW1MC&pg	Palliative	Not Provided 504	REXOLATE Approved Use To relieve symptoms of acute gout, to relieve pain from musculoskeletal conditions, to relieve symptoms of osteoarthritis, to treat rheumatic fever.
Rheumatic fever 6 Sources: (2009) 'Nurse's Drug 2009', p. 949, retrieved from: https://books.google.com/books?id=pobp8JRNW1MC&pg	Primary	Not Provided 504	REXOLATE Approved Use To relieve symptoms of acute gout, to relieve pain from musculoskeletal conditions, to relieve symptoms of osteoarthritis, to treat rheumatic fever.

PubMed

Title	Date	PubMed
Simultaneous determination of reduced and oxidized glutathione in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry.	2001 Jun 5	11419750
Superoxide dismutase activity and electrochemical study of the binuclear [Cu(TSA)2py]2 complex.	2002	12437156
Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway.	2002 Aug	12140745
Preconcentration of lead with Amberlite XAD-2 and Amberlite XAD-7 based chelating resins for its determination by flame atomic absorption spectrometry.	2002 Mar 11	18968550
A new LC/MS-method for the quantitation of acrylamide based on a stable isotope dilution assay and derivatization with 2-mercaptobenzoic acid. Comparison with two GC/MS methods.	2003 Dec 31	14690366
Zn(II)-catalyzed thiolysis of oxiranes in water under neutral conditions.	2003 Oct 17	14535811
Effect of taxol and okadaic acid on microtubule dynamics in thimerosal-arrested primary mouse oocytes: a confocal study.	2003 Sep	14519558
Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres.	2004 Apr 1	15010124
One-pot synthesis of benzo[e]1,4-oxathiepin-5-ones under solvent-free condition via self-promoted thiolysis of 1,2-epoxides.	2004 Dec 10	15575757
Using model complexes to augment and advance metalloproteinase inhibitor design.	2004 May 17	15132609
Determination of thiocyl in biological samples by liquid chromatography with ThioGlo 3 derivatization.	2004 Oct 5	15315779
Self-assembly of dialkyltin moieties and mercaptobenzoic acid into macrocyclic complexes with hydrophobic "pseudo-cage" or double-cavity structures: supramolecular infrastructures involving intermolecular C-H...S weak hydrogen bonds and pi-pi interactions.	2005 Dec 23	16187379
Chelating sorbents based on silica gel and their application in atomic spectrometry.	2005 Mar	15703917
Determination of mercury complexation in coastal and estuarine waters using competitive ligand exchange method.	2005 Sep 1	16190218
Analysis of acrylamide in food samples by capillary zone electrophoresis.	2006 Jul 7	16310205
Competing ligand exchange-solid phase extraction method for the determination of the complexation of dissolved inorganic mercury (II) in natural waters.	2007 Aug 29	17719908
Field amplified sample injection-capillary electrophoresis-tandem mass spectrometry for the analysis of acrylamide in foodstuffs.	2007 Aug 3	17383666
In vitro-refolding of a single-chain Fv fragment in the presence of heteroaromatic thiols.	2008 Apr 30	18321603
Cleavage of focal adhesion kinase is an early marker and modulator of oxidative stress-induced apoptosis.	2008 Jan 10	17888894
Removal of malodorous organic sulfides with molecular oxygen and visible light over metal phthalocyanine.	2008 Mar 21	17707582
Thimerosal and the relevance of patch-test reactions in children.	2008 Sep-Oct	18845117
Zinc ions cause the thimerosal-induced signal of fluorescent calcium probes in lymphocytes.	2009 Feb	18977527
The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.	2009 Jul	19427195
Expression of metallothionein mRNAs on mouse cerebellum microglia cells by thimerosal and its metabolites.	2009 Jun 30	19386279
Ultrasonic-assisted precolumn derivatization-HPLC determination of acrylamide formed in Radix Asparagi during heating process.	2009 May 1	19269121
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.	2010 Jan	19484470
Intercalation of anionic organic ultraviolet ray absorbers into layered zinc hydroxide nitrate.	2010 Jul 1	20378120
Sensitization effect of thimerosal is mediated in vitro via reactive oxygen species and calcium signaling.	2010 Jul-Aug	20457211
Poly[(dimethyl-formamide)(μ(4)-2,2'-sulfanediyldibenzoato)nickel(II)].	2010 Mar 6	21580481
2-[(2-Carboxy-phen-yl)disulfan-yl]benzoic acid-4,4'-bipyridyl N,N'-dioxide (1/2).	2010 May 26	21579515
Ultraviolet treatment and biodegradation of dibenzothiophene: Identification and toxicity of products.	2010 Nov	20862751
14-(1,3-Benzodioxol-5-yl)-7,14-dihydro-dibenzo[a,j]acridine.	2010 Nov 6	21589382
Low molecular weight thiols reduce thimerosal neurotoxicity in vitro: modulation by proteins.	2010 Oct 29	20696200

Patents

Sample Use Guides

In Vivo Use Guide

Acute gout: initial dose is 100 mg every 3 to 4 hours for 2 days, then 100 mg daily. Painful musculoskeletal conditions: 50 to 100 mg daily or every other day. Osteoarthritis: 10 mg 3 times/week for several weeks then once a week, usually up to a total dosage of 2.5 g. Rheumatic fever: initial dose is 100 to 150 mg every 4 to 8 hours for 3 days, then 100 mg two times daily.

Route of Administration: Other

In Vitro Use Guide

Human platelets were incubated with thiosalicylic acid at 0.5 mM for 3 min in the presence of 1,2 and 1,3-glyceryl dinitrate. A concentration-dependent inhibition of platelet aggregation was observed.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:17:19 UTC 2023` Edited by `admin` on `Fri Dec 15 15:17:19 UTC 2023`
Record UNII	CIP6LXN5XW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

THIOSALICYLIC ACID

Official Name

English

Thiosalicylic acid [WHO-DD]

Common Name

English

O-SULFHYDRYLBENZOIC ACID

Systematic Name

English

THIOSALICYLATE

Systematic Name

English

2-MERCAPTOBENZOIC ACID

Systematic Name

English

THIOSALICYLIC ACID [USP IMPURITY]

Common Name

English

THIOSALICYLIC ACID [MI]

Common Name

English

NSC-660640

Code

English

THIOSALICYLIC ACID [INCI]

Common Name

English

NSC-2184

Code

English

2-THIOSALICYLIC ACID [HSDB]

Common Name

English

Classification Tree Code System Code

EPA PESTICIDE CODE

78903

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

NCI_THESAURUS

C257

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

Code System Code Type Description

NSC

660640

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

WIKIPEDIA

THIOSALICYLIC ACID

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

MESH

C441201

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

NSC

2184

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

PUBCHEM

5443

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

RXCUI

322165

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

EPA CompTox

DTXSID4049032

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

CHEBI

59124

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

RXCUI

91099

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

ALTERNATIVE

FDA UNII

CIP6LXN5XW

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

CHEBI

59127

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

MERCK INDEX

m10783

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

Merck Index

CAS

147-93-3

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

HSDB

2739

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

DRUG BANK

DB14026

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

NCI_THESAURUS

C87327

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

SMS_ID

100000183747

Created by admin on Fri Dec 15 15:17:20 UTC 2023 , Edited by admin on Fri Dec 15 15:17:20 UTC 2023

PRIMARY

ECHA (EC/EINECS)

205-704-3

Created by admin on Fri Dec 15 15:17:19 UTC 2023 , Edited by admin on Fri Dec 15 15:17:19 UTC 2023

PRIMARY

Related Record Type Details


					C2D9ITW04B

SODIUM THIOSALICYLATE

SALT/SOLVATE -> PARENT

Related Record Type Details


					2225PI3MOV

THIMEROSAL

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

USP

Amount:

Related Record Type Details


					CIP6LXN5XW

THIOSALICYLIC ACID

ACTIVE MOIETY

Details

SMILES

InChI

DescriptionSources: ISBN: 978-0-7637-6547-7, 'Nurse's Drug 2009' (2009), p. 949, Retrieved from https://books.google.com/books?id=pobp8JRNW1MC&pg | https://www.ncbi.nlm.nih.gov/pubmed/13563950

Approval Year

Targets

Conditions

Approved Use

Approved Use

Approved Use

Approved Use

PubMed

Patents

Sample Use Guides

Description
Sources: ISBN: 978-0-7637-6547-7, 'Nurse's Drug 2009' (2009), p. 949, Retrieved from https://books.google.com/books?id=pobp8JRNW1MC&pg | https://www.ncbi.nlm.nih.gov/pubmed/13563950